230 related articles for article (PubMed ID: 16308573)
1. Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor.
Chutipongtanate S; Nakagawa Y; Sritippayawan S; Pittayamateekul J; Parichatikanond P; Westley BR; May FE; Malasit P; Thongboonkerd V
J Clin Invest; 2005 Dec; 115(12):3613-22. PubMed ID: 16308573
[TBL] [Abstract][Full Text] [Related]
2. An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix.
Govindaraj A; Selvam R
BJU Int; 2002 Aug; 90(3):336-44. PubMed ID: 12133075
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometric identification of human phosphate cytidylyltransferase 1 as a novel calcium oxalate crystal growth inhibitor purified from human renal stone matrix.
Priyadarshini ; Singh SK; Tandon C
Clin Chim Acta; 2009 Oct; 408(1-2):34-8. PubMed ID: 19595683
[TBL] [Abstract][Full Text] [Related]
4. Urinary trefoil factor 1 is a novel potent inhibitor of calcium oxalate crystal growth and aggregation.
Thongboonkerd V; Chutipongtanate S; Semangoen T; Malasit P
J Urol; 2008 Apr; 179(4):1615-9. PubMed ID: 18295252
[TBL] [Abstract][Full Text] [Related]
5. Peeping into human renal calcium oxalate stone matrix: characterization of novel proteins involved in the intricate mechanism of urolithiasis.
Aggarwal KP; Tandon S; Naik PK; Singh SK; Tandon C
PLoS One; 2013; 8(7):e69916. PubMed ID: 23894559
[TBL] [Abstract][Full Text] [Related]
6. Alpha-1-microglobulin: inhibitory effect on calcium oxalate crystallization in vitro and decreased urinary concentration in calcium oxalate stone formers.
Tardivel S; Médétognon J; Randoux C; Kébédé M; Drüeke T; Daudon M; Hennequin C; Lacour B
Urol Res; 1999 Aug; 27(4):243-9. PubMed ID: 10460893
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic Insights into the Antilithiatic Proteins from Terminalia arjuna: A Proteomic Approach in Urolithiasis.
Mittal A; Tandon S; Singla SK; Tandon C
PLoS One; 2016; 11(9):e0162600. PubMed ID: 27649531
[TBL] [Abstract][Full Text] [Related]
8. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
Srinivasan S; Kalaiselvi P; Varalakshmi P
Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
[TBL] [Abstract][Full Text] [Related]
9. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.
Nakagawa Y; Ahmed M; Hall SL; Deganello S; Coe FL
J Clin Invest; 1987 Jun; 79(6):1782-7. PubMed ID: 3584470
[TBL] [Abstract][Full Text] [Related]
10. Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones.
Mushtaq S; Siddiqui AA; Naqvi ZA; Rattani A; Talati J; Palmberg C; Shafqat J
Clin Chim Acta; 2007 Sep; 384(1-2):41-7. PubMed ID: 17610860
[TBL] [Abstract][Full Text] [Related]
11. The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin.
Worcester EM; Blumenthal SS; Beshensky AM; Lewand DL
J Bone Miner Res; 1992 Sep; 7(9):1029-36. PubMed ID: 1414495
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of an anticalcifying protein from the seeds of Trachyspermum ammi (L.).
Kaur T; Bijarnia RK; Singla SK; Tandon C
Protein Pept Lett; 2009; 16(2):173-81. PubMed ID: 19200041
[TBL] [Abstract][Full Text] [Related]
13. Novel antilithiatic cationic proteins from human calcium oxalate renal stone matrix identified by MALDI-TOF-MS endowed with cytoprotective potential: an insight into the molecular mechanism of urolithiasis.
Aggarwal KP; Tandon S; Naik PK; Singh SK; Tandon C
Clin Chim Acta; 2013 Jan; 415():181-90. PubMed ID: 23123287
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of bikunin on calcium oxalate crystallization in vitro and urinary bikunin decrease in renal stone formers.
Médétognon-Benissan J; Tardivel S; Hennequin C; Daudon M; Drüeke T; Lacour B
Urol Res; 1999; 27(1):69-75. PubMed ID: 10092156
[TBL] [Abstract][Full Text] [Related]
15. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
Atmani F; Lacour B; Daudon M
Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
[TBL] [Abstract][Full Text] [Related]
16. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
Atmani F; Khan SR
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
[TBL] [Abstract][Full Text] [Related]
17. Oxidative Modifications Switch Modulatory Activities of Urinary Proteins From Inhibiting to Promoting Calcium Oxalate Crystallization, Growth, and Aggregation.
Chaiyarit S; Thongboonkerd V
Mol Cell Proteomics; 2021; 20():100151. PubMed ID: 34562649
[TBL] [Abstract][Full Text] [Related]
18. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
Asokan D; Kalaiselvi P; Varalakshmi P
Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
[TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of modulating activities of native human urinary Tamm-Horsfall protein on calcium oxalate crystallization, growth, aggregation, crystal-cell adhesion and invasion through extracellular matrix.
Noonin C; Peerapen P; Yoodee S; Kapincharanon C; Kanlaya R; Thongboonkerd V
Chem Biol Interact; 2022 Apr; 357():109879. PubMed ID: 35263610
[TBL] [Abstract][Full Text] [Related]
20. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
Coe FL; Nakagawa Y; Asplin J; Parks JH
Miner Electrolyte Metab; 1994; 20(6):378-84. PubMed ID: 7783700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
